Title : Understanding the protective effects of SGLT2 inhibitors in type 2 diabetes patients with chronic kidney disease.

Pub. Date : 2022 Jan

PMID : 34908510






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 INTRODUCTION: Sodium-glucose co-transporter type 2 inhibitors (SGLT2is) were developed as glucose-lowering agents for the management of type 2 diabetes (T2D). Glucose solute carrier family 5 member 2 Homo sapiens
2 INTRODUCTION: Sodium-glucose co-transporter type 2 inhibitors (SGLT2is) were developed as glucose-lowering agents for the management of type 2 diabetes (T2D). Glucose solute carrier family 5 member 2 Homo sapiens